Molecular subtyping of male breast cancer by immunohistochemistry (Q42496958)

1 November 2017

Molecular subtyping of male breast cancer by immunohistochemistry (English)

1 reference

1 November 2017

1 reference

1 reference

9

Paul J van Diest

1 reference

1 November 2017

Robert Kornegoor

1

1 reference

1 November 2017

Anoek H J Verschuur-Maes

2

1 reference

1 November 2017

Horst Buerger

3

1 reference

1 November 2017

Marieke C H Hogenes

4

1 reference

1 November 2017

Peter C de Bruin

5

1 reference

1 November 2017

Joost J Oudejans

6

1 reference

1 November 2017

Petra van der Groep

7

1 reference

1 November 2017

Bernd Hinrichs

8

1 reference

1 November 2017

4 November 2011

1 reference

1 November 2017

1 reference

1 November 2017

25

1 reference

1 November 2017

3

1 reference

1 November 2017

398-404

1 reference

describes a project that uses

1 November 2017

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2011.174

0 references

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Current management of male breast cancer. A review of 104 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Male breast cancer: a population-based comparison with female breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Breast carcinoma in men: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Men with breast cancer have same disease-specific and event-free survival as women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Basal carcinoma of the breast revisited: an old entity with new interpretations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Immunohistochemical characterization of subtypes of male breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Cytokeratin profiles of male breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

The role of local estrogen biosynthesis in males and females

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Oestrogen producing enzymes and mammary carcinogenesis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Breast cancer subtypes and the risk of local and regional relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Breast cancer risk among male BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Prevalence of BRCA1 and BRCA2 mutations in male breast cancer patients in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.174

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MODPATHOL.2011.174

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference